924
Participants
Start Date
February 8, 2022
Primary Completion Date
August 31, 2026
Study Completion Date
August 31, 2026
Dihydroartemisinin-piperaquine (DP)
Duo-Cotecxin 20mg/160mg tabs by Holley-Cotec, Beijing, China Each treatment with DP will consist of half-strength tablets given once a day for 3 consecutive days according to weight-based guidelines.
DP Placebo
Placebos will be identical appearance to DP.
IDRC - Tororo Research Clinic, Tororo
Stanford University
OTHER
Infectious Diseases Research Collaboration, Uganda
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Karolinska Institutet
OTHER
Grant Dorsey, M.D, Ph.D.
OTHER